About Retro Bio
Retro Bio is a company based in San Francisco (United States) founded in 2020 by Sheng Ding, Matt Buckley, and Joe Betts Lacroix. It operates as a HealthTech. Retro Bio has raised $180 million across 1 funding round from investors including Sam Altman. The company has 21 employees as of December 31, 2022. Retro Bio offers products and services including Aging Therapies. Retro Bio operates in a competitive market with competitors including AMN Healthcare, Cross Country Healthcare, Medical Solutions, Toothio and Aya Healthcare, among others.
- Headquarter San Francisco, United States
- Employees 21 as on 31 Dec, 2022
- Founders Sheng Ding, Matt Buckley, Joe Betts Lacroix
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$9.53 K (USD)34as on Dec 31, 2022
-
Net Profit
$-4.49 K (USD)-230as on Dec 31, 2022
-
EBITDA
-
Total Equity Funding
$180 M (USD)
in 1 rounds
-
Latest Funding Round
$180 M (USD), Series D
Apr 06, 2022
-
Investors
-
Employee Count
21
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Retro Bio
Retro Bio offers a comprehensive portfolio of products and services, including Aging Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Therapies are developed to reverse age-related diseases effectively.
Unlock access to complete
Unlock access to complete
Funding Insights of Retro Bio
Retro Bio has successfully raised a total of $180M through 1 strategic funding round. The most recent funding activity was a Series D round of $180 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series D — $180.0M
-
First Round
First Round
(06 Apr 2022)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2022 | Amount | Series D - Retro Bio | Valuation | Sam Altman |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Retro Bio
Retro Bio has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Sam Altman. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
SA
Sam Altman |
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Retro Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Retro Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Retro Bio Comparisons
Competitors of Retro Bio
Retro Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AMN Healthcare, Cross Country Healthcare, Medical Solutions, Toothio and Aya Healthcare, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AMN Healthcare is recognized as a leading healthcare staffing provider.
|
|
| domain | founded_year | HQ Location |
Healthcare staffing and workforce solutions are delivered nationwide.
|
|
| domain | founded_year | HQ Location |
Travel nursing jobs are offered to certified nurses nationwide.
|
|
| domain | founded_year | HQ Location |
Provider of dental staffing services
|
|
| domain | founded_year | HQ Location |
Provides medical staffing services to healthcare facilities.
|
|
| domain | founded_year | HQ Location |
Provider of clinical trial tooling & staffing services for physicians
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Retro Bio
Frequently Asked Questions about Retro Bio
When was Retro Bio founded?
Retro Bio was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Where is Retro Bio located?
Retro Bio is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Retro Bio?
Joe Betts Lacroix is the current CEO of Retro Bio. They have also founded this company.
Is Retro Bio a funded company?
Retro Bio is a funded company, having raised a total of $180M across 1 funding round to date. The company's 1st funding round was a Series D of $180M, raised on Apr 06, 2022.
How many employees does Retro Bio have?
As of Dec 31, 2022, the latest employee count at Retro Bio is 21.
What is the annual revenue of Retro Bio?
Annual revenue of Retro Bio is $9.53K as on Dec 31, 2022.
What does Retro Bio do?
Retro Bio is focused on developing therapies that target aging mechanisms to increase healthy human lifespan. Age-related diseases are addressed at their source using advanced technologies like single-cell multi-omics and targeted delivery systems. Interventions are designed based on robust proofs of concept in mammals, with a feasible path to human clinical translation. The company operates as a generational pharma entity, structured as a portfolio of bets, emphasizing speed, vertical integration, and a culture of kindness and rigor within the biotechnology sector.
Who are the top competitors of Retro Bio?
Retro Bio's top competitors include AMN Healthcare, Medical Solutions and Health Carousel.
What products or services does Retro Bio offer?
Retro Bio offers Aging Therapies.
Who are Retro Bio's investors?
Retro Bio has 1 investor. Key investors include Sam Altman.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.